Skip to main content
Contact Us
search

Joseph Tkacz

Author Biography

Joseph.Tkacz@inovalon.com
Connect on LinkedIn

Joseph Tkacz

Senior Director, Health Economics and Outcomes Research

Joseph works closely with life sciences clients to design observational research studies, health economic evaluations, and market landscape assessments. Joseph has particular expertise in the design and execution of observational, retrospective database analyses, and his work has been published across a wide range of therapeutic areas.

Joseph has more than 15 years of experience in health outcomes and health services research spanning the academic, non-profit, and private sectors, and has authored/co-authored over 50 scholarly manuscripts in a variety of clinical and health services journals, along with over 180 conference abstracts. Joseph has received research awards from several professional societies including the International Society for Pharmacoeconomic and Outcomes Research, Academy of Managed Care Pharmacy, and the National Comprehensive Cancer Network; he is also recognized as a Certified Clinical Research Professional by the Society of Clinical Research Associates.

Prior to joining Inovalon, Joseph held the position of Principal at Avalere Health, and also served as Research Leader for IBM Watson Health. In both roles, he was responsible for leading the design and implementation of health economics, health outcomes, and epidemiological studies for life sciences clients. He also held the position of Director of Analytics for Health Analytics, LLC, where he was a principal researcher managing a portfolio of health outcomes research studies and associated analytic staff.

Joseph holds a Bachelor of Science degree and a Master of Science degree in experimental psychology.

Authored Content

Filter

May 3, 2023
Poster Presentation

Long COVID-19 Associated with 5-Fold Increase in Total Medical Costs and Greater Use of Inpatient and Outpatient Services Compared to Non-Long COVID-19: An Analysis of Real World Data.

Chacon-Araya M., Tkacz J.P., Zagari M., Bello T., Lewing B., Brusky S.
This study assessed real-world evidence data on the prevalence and impact of long COVID (LC) to establish a baseline for the value of potential therapeutic interventions.
Read More
May 3, 2023
Poster Presentation

Treatment Patterns and Healthcare Resource Utilization in Patients with Relapsed/Refractory Multiple Myeloma (RRMM), Classified by Urbanicity and Ethnicity.

Molinari A., Boytsov N., Tkacz J.P., Wang P., Perera S., Norris, K., Gorsh B.
RRMM remains incurable making long-term clinical management complex. Furthermore, disparities in mortality, incidence and treatment utilization exist, with newer, more effective and expensive therapies underutilized. Better understanding of disparities in healthcare resource utilization (HCRU) and treatment patterns is necessary to improve outcomes for these patients.
Read More
May 3, 2023
Poster Presentation

An Assessment of the Direct and Indirect Costs of Bladder Cancer Preceding and Following a Cystectomy: A Real-World Evidence Study

Tkacz J.P., Ireland I., Norris K., Agatep B., Forman C., Ellis L., Khaki A.
This study estimated the direct and indirect costs of bladder cancer prior to and following cystectomy.
Read More
May 3, 2023
Poster Presentation

Assessment of Medically-Attended COVID-19 Patient Risk Profiles and Health Care Resource Utilization (HCRU) and Costs in the U.S.

Chacon-Araya M., Tkacz J.P., Zagari M., Bello T., Lewing B., Brusky S.
This study assessed healthcare costs for medically attended COVID-19 (MAC) patients vs. matched controls not presenting with COVID-19, to serve as a baseline for the value of potential therapeutics.
Read More
March 21, 2023
Presentation

National Projection of U.S. Patients Potentially Ineligible for Existing COVID-19 Treatments

Chacon-Araya M, Tkacz JP, Zagari M, Bello T, Lewing B, Brusky S
Accepted for presentation at Academy of Managed Care Pharmacy 2023. Findings available upon request. Contact us for more information.
Read More
February 24, 2023
Presentation

Racial and Ethnic Disparities in Treatment of Uncontrolled Disease Among Severe, Persistent Asthma Patients: An Analysis of Medicare Fee-for-Service Claims

Carr T, Chung Y, Ambrose C, Rane P, Lindsley AW, Tkacz JP, Burnette A
Accepted for presentation at American Academy of Allergy, Asthma, and Immunology 2023. Findings available upon request. Contact us for more information.
Read More
December 13, 2022
Presentation

Real-World Effectiveness and Economic Impact Associated with Chimeric Antigen Receptor T-Cell Therapy Among Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in US

Chihara D, Liao L, Tkacz J, Lewing B, Franco A, Kilgore K, Nastoupil L, Chen L
The aim of the study was to examine the outcomes and economic impact among older patients with DLBCL receiving CAR T-cell therapy in a real-world setting in the United States.
Read More
December 10, 2022
Presentation

Real-World Effectiveness and Economic Impact Associated with Chimeric Antigen Receptor T-cell Therapy Among Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Chihara D, Liao L, Chen L,  Tkacz JP, Franco A, Lewing B, Kilgore K,   Nastoupil L 
Accepted for presentation at American Society of Hematology (ASH) Annual Meeting 2022. Findings available upon request. Contact us for more information.
Read More